Canada Life’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$582M Buy
630,459
+3,593
+0.6% +$3.64M 1.04% 14
2025
Q4
$674M Sell
626,866
-189,965
-23% -$182M 1.17% 12
2025
Q3
$593M Buy
816,831
+44,164
+6% +$32.9M 0.85% 17
2025
Q2
$603M Buy
772,667
+7,812
+1% +$6.07M 0.96% 15
2025
Q1
$632M Buy
764,855
+11,421
+2% +$9.5M 1.11% 11
2024
Q4
$582M Sell
753,434
-32,328
-4% -$26.8M 1% 13
2024
Q3
$697M Buy
785,762
+17,970
+2% +$16.2M 1.21% 8
2024
Q2
$696M Buy
767,792
+49,013
+7% +$39.2M 1.31% 8
2024
Q1
$559M Buy
718,779
+11,054
+2% +$7.87M 1.13% 9
2023
Q4
$411M Sell
707,725
-18,280
-3% -$10.7M 0.9% 17
2023
Q3
$390M Buy
726,005
+3,476
+0.5% +$1.79M 0.94% 13
2023
Q2
$340M Buy
722,529
+139,439
+24% +$58.5M 0.81% 19
2023
Q1
$200M Buy
583,090
+9,341
+2% +$3.15M 0.5% 33
2022
Q4
$211M Sell
573,749
-50,484
-8% -$17.9M 0.55% 29
2022
Q3
$202M Sell
624,233
-5,805
-0.9% -$1.84M 0.57% 27
2022
Q2
$205M Sell
630,038
-134,138
-18% -$40.3M 0.54% 32
2022
Q1
$231M Sell
764,176
-10,387
-1% -$2.67M 0.48% 38
2021
Q4
$213M Sell
774,563
-17,721
-2% -$4.49M 0.44% 44
2021
Q3
$184M Buy
792,284
+3,308
+0.4% +$816K 0.43% 46
2021
Q2
$181M Buy
788,976
+1,704
+0.2% +$342K 0.41% 47
2021
Q1
$146M Sell
787,272
-27,669
-3% -$5.41M 0.36% 52
2020
Q4
$137M Buy
814,941
+58,985
+8% +$8.81M 0.26% 88
2020
Q3
$112M Buy
755,956
+2,927
+0.4% +$453K 0.24% 100
2020
Q2
$123M Buy
753,029
+2,805
+0.4% +$431K 0.28% 87
2020
Q1
$105M Buy
750,224
+42,658
+6% +$5.86M 0.28% 86
2019
Q4
$92.3M Sell
707,566
-286,174
-29% -$33.2M 0.2% 113
2019
Q3
$111M Sell
993,740
-33,833
-3% -$3.77M 0.26% 93
2019
Q2
$114M Buy
1,027,573
+265,621
+35% +$31.3M 0.26% 91
2019
Q1
$98.6M Buy
761,952
+81,768
+12% +$9.94M 0.26% 95
2018
Q4
$75M Sell
680,184
-220,031
-24% -$24.6M 0.21% 109
2018
Q3
$96.7M Sell
900,215
-74,773
-8% -$7.48M 0.23% 99
2018
Q2
$83.2M Buy
974,988
+86,352
+10% +$7.09M 0.2% 119
2018
Q1
$68.9M Buy
888,636
+8,843
+1% +$712K 0.17% 142
2017
Q4
$74.3M Sell
879,793
-113,489
-11% -$9.66M 0.17% 129
2017
Q3
$84.3M Buy
993,282
+46,679
+5% +$3.83M 0.21% 108
2017
Q2
$77.8M Sell
946,603
-155,128
-14% -$12.7M 0.21% 105
2017
Q1
$92.6M Buy
1,101,731
+10,430
+1% +$835K 0.25% 89
2016
Q4
$80.5M Buy
1,091,301
+86,552
+9% +$6.45M 0.23% 102
2016
Q3
$80.6M Buy
1,004,749
+23,965
+2% +$1.92M 0.23% 98
2016
Q2
$77.1M Buy
980,784
+194,542
+25% +$14.6M 0.23% 98
2016
Q1
$56.5M Buy
786,242
+28,589
+4% +$2.16M 0.21% 115
2015
Q4
$63.9M Buy
757,653
+81,832
+12% +$6.79M 0.25% 99
2015
Q3
$56.6M Sell
675,821
-124,388
-16% -$10.5M 0.22% 103
2015
Q2
$66.7M Sell
800,209
-135,408
-14% -$10.3M 0.23% 96
2015
Q1
$67.8M Buy
935,617
+27,877
+3% +$1.98M 0.23% 101
2014
Q4
$62.5M Sell
907,740
-247,347
-21% -$16.7M 0.21% 109
2014
Q3
$75.1M Buy
1,155,087
+98,966
+9% +$6.27M 0.25% 94
2014
Q2
$65.5M Buy
1,056,121
+152,441
+17% +$9.1M 0.21% 108
2014
Q1
$52.9M Buy
903,680
+37,321
+4% +$2.08M 0.19% 124
2013
Q4
$44.4M Buy
866,359
+138,174
+19% +$6.92M 0.16% 134
2013
Q3
$36.6M Buy
728,185
+550,835
+311% +$28.8M 0.14% 156
2013
Q2
$8.72M Buy
+177,350
New +$9.65M 0.06% 267

Other funds holding LLY

Canada Life's LLY Position: Q1 2026 in Review

Canada Life increased its Eli Lilly (LLY) stake by 0.57% in Q1 2026, buying an estimated $3.64M and bringing the position to 630,459 shares worth $582M. The position accounts for 1.04% of the portfolio, ranked #14.

Canada Life first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $697M in Q3 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Canada Life held 630,459 shares of Eli Lilly worth $582M as of Q1 2026.
  • Canada Life bought 3,593 Eli Lilly shares in Q1 2026, an estimated $3.64M.
  • Eli Lilly made up 1.04% of Canada Life's portfolio in Q1 2026, its #14 holding.
  • Canada Life first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Eli Lilly position peaked at $697M in Q3 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.